|
[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? The Lancet, 357, 539-545. [Google Scholar] [CrossRef]
|
|
[3]
|
Liu, G., Ke, L.C. and Sun, S.R. (2018) Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Patients with Soft Tissue Sarcoma: A Meta-Analysis. Medicine (Baltimore), 97, e12176. [Google Scholar] [CrossRef]
|
|
[4]
|
Diem, S., Schmid, S., Krapf, M., et al. (2017) Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab. Lung Cancer, 111, 176-181. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Cha, Y.J., Park, E.J., Baik, S.H., et al. (2019) Clinical Significance of Tumor-Infiltrating Lymphocytes and Neutrophil-to-Lymphocyte Ratio in Patients with Stage III Colon Cancer Who Underwent Surgery Followed by FOLFOX Chemotherapy. Scientific Reports, 9, Article No. 11617. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Ozer-Stillman, I., Strand, L., Chang, J., et al. (2014) Meta-Analysis for the Association between Overall Survival and Progression-Free Survival in Gastrointestinal Stromal Tumor. Clinical Cancer Research, 21, 295-302. [Google Scholar] [CrossRef]
|
|
[7]
|
Schwartz, L.H., Litière, S., de Vries, E., et al. (2016) RECIST 1.1—Update and Clarification: From the RECIST Committee. European Journal of Cancer, 62, 132-137. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Kim, Y.J., Chung, W.C., Youn, G.J., et al. (2019) The Predictive Factors of Gastric Cancer Recurrence after the Completion of Adjuvant Chemotherapy in Advanced Gastric Cancer. Revista Espanola de Enfermedades Digestivas, 111, 537-542. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Jin, H., Zhang, G., Liu, X., et al. (2013) Blood Neutrophil-Lymphocyte Ratio Predicts Survival for Stages III-IV Gastric Cancer Treated with Neoadjuvant Chemotherapy. World Journal of Surgical Oncology, 11, 112. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Shaul, M.E. and Fridlender, Z.G. (2017) Neutrophils as Active Regulators of the Immune System in the Tumor Microenvironment. Journal of Leukocyte Biology, 102, 343-349. [Google Scholar] [CrossRef]
|
|
[11]
|
Hoffmann, T.K., Dworacki, G., Tsukihiro, T., et al. (2002) Spontaneous Apoptosis of Circulating T Lymphocytes in Patients with Head and Neck Cancer and Its Clinical Importance. Clinical Cancer Research, 8, 2553-2562.
|
|
[12]
|
Zheng, X., et al. (2017) Prognostic Role of Tumor-Infiltrating Lymphocytes in Gastric Cancer: A Meta-Analysis. Oncotarget, 8, 57386-57398. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Yu, X., Zhang, Z., Wang, Z., et al. (2016) Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis. Clinical and Translational Oncology, 18, 497-506. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Sa, R. (2001) Progress in Human Tumour Immunology and Immunotherapy. Nature, 411, 380-384. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Bambace, N.M. and Holmes, C.E. (2011) The Platelet Contribution to Cancer Progression. Journal of Thrombosis and Haemostasis, 9, 237-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Ma, X., Wang, Y., Sheng, H., et al. (2014) Prognostic Significance of Thrombocytosis, Platelet Parameters and Aggregation Rates in Epithelial Ovarian Cancer. Journal of Obstetrics and Gynaecology Research, 40, 178-183. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Menter, D.G., Tucker, S.C., Kopetz, S., et al. (2014) Platelets and Cancer: A Casual or Causal Relationship: Revisited. Cancer and Metastasis Reviews, 33, 231-269. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Sierko, E. and Wojtukiewicz, M.Z. (2004) Platelets and Angiogenesis in Malignancy. Seminars in Thrombosis and Hemostasis, 30, 95-108. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Pw, S. and Fr, B. (2003) Tumour Necrosis Factor Alpha: A Potential Target for the Therapy of Solid Tumours. The Lancet Oncology, 4, 565-573. [Google Scholar] [CrossRef]
|
|
[20]
|
Wang, J., Qu, J.L., Li, Z., et al. (2018) Pretreatment Platelet-to-Lymphocyte Ratio Is Associated with the Response to First-Line Chemotherapy and Survival in Patients with Metastatic Gastric Cancer. Journal of Clinical Laboratory Analysis, 32. [Google Scholar] [CrossRef] [PubMed]
|